396 related articles for article (PubMed ID: 19506956)
21. Breast reconstruction in patients with personal and family history of breast cancer undergoing contralateral prophylactic mastectomy, a 10-year experience.
Unukovych D; Sandelin K; Wickman M; Arver B; Johansson H; Brandberg Y; Liljegren A
Acta Oncol; 2012 Sep; 51(7):934-41. PubMed ID: 22409595
[TBL] [Abstract][Full Text] [Related]
22. Are mastectomy rates really increasing in the United States?
Habermann EB; Abbott A; Parsons HM; Virnig BA; Al-Refaie WB; Tuttle TM
J Clin Oncol; 2010 Jul; 28(21):3437-41. PubMed ID: 20548000
[TBL] [Abstract][Full Text] [Related]
23. Should the use of contralateral prophylactic mastectomy be increasing as it is?
Wood WC
Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
[TBL] [Abstract][Full Text] [Related]
24. Predictors for contralateral prophylactic mastectomy in breast cancer patients.
Fu Y; Zhuang Z; Dewing M; Apple S; Chang H
Int J Clin Exp Pathol; 2015; 8(4):3748-64. PubMed ID: 26097557
[TBL] [Abstract][Full Text] [Related]
25. Incremental risk associated with contralateral prophylactic mastectomy and the effect on adjuvant therapy.
Eck DL; Perdikis G; Rawal B; Bagaria S; McLaughlin SA
Ann Surg Oncol; 2014 Oct; 21(10):3297-303. PubMed ID: 25047470
[TBL] [Abstract][Full Text] [Related]
26. Contralateral prophylactic mastectomy in breast cancer patients who test negative for BRCA mutations.
Howard-McNatt M; Schroll RW; Hurt GJ; Levine EA
Am J Surg; 2011 Sep; 202(3):298-302. PubMed ID: 21871984
[TBL] [Abstract][Full Text] [Related]
27. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
McLaughlin CC; Lillquist PP; Edge SB
Cancer; 2009 Dec; 115(23):5404-12. PubMed ID: 19787635
[TBL] [Abstract][Full Text] [Related]
28. Increased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP database.
Osman F; Saleh F; Jackson TD; Corrigan MA; Cil T
Ann Surg Oncol; 2013 Oct; 20(10):3212-7. PubMed ID: 23846780
[TBL] [Abstract][Full Text] [Related]
29. Factors that influence surgical choices in women with breast carcinoma.
Staradub VL; Hsieh YC; Clauson J; Langerman A; Rademaker AW; Morrow M
Cancer; 2002 Sep; 95(6):1185-90. PubMed ID: 12216083
[TBL] [Abstract][Full Text] [Related]
30. Fear of recurrence and perceived survival benefit are primary motivators for choosing mastectomy over breast-conservation therapy regardless of age.
Fisher CS; Martin-Dunlap T; Ruppel MB; Gao F; Atkins J; Margenthaler JA
Ann Surg Oncol; 2012 Oct; 19(10):3246-50. PubMed ID: 22833001
[TBL] [Abstract][Full Text] [Related]
31. Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.
Bafford AC; Burstein HJ; Barkley CR; Smith BL; Lipsitz S; Iglehart JD; Winer EP; Golshan M
Breast Cancer Res Treat; 2009 May; 115(1):7-12. PubMed ID: 18581232
[TBL] [Abstract][Full Text] [Related]
32. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
Kruper L; Kauffmann RM; Smith DD; Nelson RA
Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
[TBL] [Abstract][Full Text] [Related]
33. Contralateral prophylactic mastectomy: clinical and pathological features from a prospective database.
Barry PN; Johnson RR; Harkenrider MM; Freeman AB; Kruse B; Wilson MR; Pan J; Dragun AE
Am J Med Sci; 2012 Dec; 344(6):452-6. PubMed ID: 22395715
[TBL] [Abstract][Full Text] [Related]
34. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
[TBL] [Abstract][Full Text] [Related]
35. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.
Portschy PR; Kuntz KM; Tuttle TM
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25031308
[TBL] [Abstract][Full Text] [Related]
36. Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002.
Yao K; Winchester DJ; Czechura T; Huo D
Breast Cancer Res Treat; 2013 Dec; 142(3):465-76. PubMed ID: 24218052
[TBL] [Abstract][Full Text] [Related]
37. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
[TBL] [Abstract][Full Text] [Related]
38. Local Therapy Decision-Making and Contralateral Prophylactic Mastectomy in Young Women with Early-Stage Breast Cancer.
Rosenberg SM; Sepucha K; Ruddy KJ; Tamimi RM; Gelber S; Meyer ME; Schapira L; Come SE; Borges VF; Golshan M; Winer EP; Partridge AH
Ann Surg Oncol; 2015 Nov; 22(12):3809-15. PubMed ID: 25930247
[TBL] [Abstract][Full Text] [Related]
39. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
40. Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer.
Alderman AK; Hawley ST; Waljee J; Mujahid M; Morrow M; Katz SJ
Cancer; 2008 Feb; 112(3):489-94. PubMed ID: 18157830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
